FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development
This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...
Impressions : 2328
Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda’s antipsychotic pill for bipolar disorder, schizophrenia
In this week’s news, Gilead Sciences has entered into an agreement to acquire its cancer therapy partner Arcellx for US$ ...
Impressions : 948
Novo’s parent buys Catalent for US$ 16.5 bn, Lilly calls for scrutiny; Novartis acquires MorphoSys
The Novo Nordisk-Eli Lilly rivalry over obesity drugs got intensified with Novo Nordisk’s parent company acquiring contra...
Impressions : 1518
Another massive explosion in a chemical plant rocks China; Lilly discloses drug pricing data for insulin
This week, Phispers brings news that
J&J and Bayer have settled more than 25,000 lawsuits in the US against
their blood t...
Impressions : 1938
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.